Date: August 31, 2019
Clinical Trials for CAD Sponsored by Sanofi Genzyme.
The CAD Studies are now recruiting adults ages 18 and older with primary cold agglutinin disease (CAD). The purpose of the CAD Studies is to determine the safety and effectiveness of an investigational medication when compared to placebo for primary CAD. Individuals will be evaluated to determine their eligibility to participate. The investigational medication, study-related medical exams, and study-related laboratory tests will be provided to participants at no cost.
A special website has been created to provide more information about the CAD Studies. This site includes information on what to expect if you are enrolled and provides a list of participating research sites. Talk to your doctor and visit:
to learn more.
This information is sponsored by Sanofi Genzyme.